Free Trial

Cinemark (NYSE:CNK) Stock Rating Upgraded by Wedbush

Cinemark logo with Consumer Discretionary background

Wedbush upgraded shares of Cinemark (NYSE:CNK - Free Report) from a neutral rating to an outperform rating in a research report released on Friday, Marketbeat reports. They currently have $37.00 price target on the stock, up from their prior price target of $32.00. Wedbush also issued estimates for Cinemark's Q3 2025 earnings at $0.55 EPS, FY2025 earnings at $1.34 EPS and Q2 2026 earnings at $0.70 EPS.

A number of other research analysts have also recently commented on CNK. Barrington Research reissued an "outperform" rating and issued a $36.00 price target on shares of Cinemark in a report on Monday, May 5th. JPMorgan Chase & Co. boosted their price target on Cinemark from $34.00 to $35.00 and gave the stock an "overweight" rating in a report on Monday, May 5th. Deutsche Bank Aktiengesellschaft began coverage on Cinemark in a report on Thursday. They issued a "buy" rating and a $36.00 price target on the stock. B. Riley began coverage on Cinemark in a report on Friday, May 16th. They issued a "neutral" rating and a $35.00 price target on the stock. Finally, Roth Capital lowered their price target on Cinemark from $36.00 to $35.00 and set a "buy" rating on the stock in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $34.00.

Check Out Our Latest Analysis on CNK

Cinemark Stock Performance

Shares of NYSE:CNK traded down $0.05 during mid-day trading on Friday, reaching $29.80. 5,315,614 shares of the company traded hands, compared to its average volume of 3,234,658. The company's 50 day moving average price is $31.41 and its 200-day moving average price is $29.23. The firm has a market cap of $3.43 billion, a PE ratio of 19.61, a PEG ratio of 1.82 and a beta of 1.88. The company has a debt-to-equity ratio of 5.53, a current ratio of 0.79 and a quick ratio of 0.76. Cinemark has a 52 week low of $20.43 and a 52 week high of $36.28.

Cinemark (NYSE:CNK - Get Free Report) last announced its quarterly earnings data on Friday, May 2nd. The company reported ($0.32) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.32). The company had revenue of $540.70 million during the quarter, compared to the consensus estimate of $604.62 million. Cinemark had a return on equity of 51.68% and a net margin of 8.17%. The firm's revenue was down 6.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.19 EPS. On average, equities analysts expect that Cinemark will post 1.93 EPS for the current fiscal year.

Cinemark Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 12th. Stockholders of record on Thursday, May 29th were given a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a dividend yield of 1.07%. The ex-dividend date of this dividend was Thursday, May 29th. Cinemark's dividend payout ratio is currently 21.05%.

Insider Activity

In other news, EVP Melissa Thomas sold 7,200 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $31.43, for a total transaction of $226,296.00. Following the transaction, the executive vice president owned 210,968 shares of the company's stock, valued at approximately $6,630,724.24. The trade was a 3.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Valmir Fernandes sold 25,000 shares of the business's stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $33.01, for a total value of $825,250.00. Following the transaction, the insider directly owned 130,612 shares in the company, valued at approximately $4,311,502.12. This represents a 16.07% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 84,724 shares of company stock valued at $2,724,435. 2.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Cinemark

Several large investors have recently modified their holdings of the stock. LPL Financial LLC increased its position in shares of Cinemark by 6.8% during the 4th quarter. LPL Financial LLC now owns 8,722 shares of the company's stock valued at $270,000 after purchasing an additional 556 shares during the last quarter. Mercer Global Advisors Inc. ADV grew its position in Cinemark by 3.8% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 16,270 shares of the company's stock valued at $504,000 after acquiring an additional 591 shares during the last quarter. Summit Investment Advisors Inc. grew its position in Cinemark by 5.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 11,546 shares of the company's stock valued at $358,000 after acquiring an additional 618 shares during the last quarter. Quarry LP grew its position in Cinemark by 41.8% in the 4th quarter. Quarry LP now owns 2,114 shares of the company's stock valued at $65,000 after acquiring an additional 623 shares during the last quarter. Finally, Sterling Capital Management LLC grew its position in Cinemark by 3.7% in the 4th quarter. Sterling Capital Management LLC now owns 18,339 shares of the company's stock valued at $568,000 after acquiring an additional 652 shares during the last quarter.

About Cinemark

(Get Free Report)

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.

See Also

Analyst Recommendations for Cinemark (NYSE:CNK)

Should You Invest $1,000 in Cinemark Right Now?

Before you consider Cinemark, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cinemark wasn't on the list.

While Cinemark currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines